Loading insider details...
Beta
Latest Form 4 (Aug 20, 2026): Sale of 11,600 ARWR shares, $1.01M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 20, 2026 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale | 11,600 | $1.01M |
| Dec 18, 2025 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Grant/Award | 7,819 | n/a |
| Dec 9, 2025 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale | 16,250 | $991.7K |
| Dec 20, 2024 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Grant/Award | 16,733 | $384.7K |
| Dec 19, 2023 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Grant/Award | 14,987 | $380.8K |
| Jan 12, 2023 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Grant/Award | 7,867 | n/a |
| Nov 22, 2022 | AVITA Medical, Inc. (RCEL) | Exercise/Conversion | 150,000 | $898.5K |
| Sep 6, 2022 | AVITA Medical, Inc. (RCEL) | Grant/Award | 2,980 | n/a |
| Jun 2, 2022 | AVITA Medical, Inc. (RCEL) | Other (see footnotes) | 23,754 | n/a |
| Feb 25, 2022 | AVITA Medical, Inc. (RCEL) | Grant/Award | 23,753 | n/a |